ANDA 70039, held by Strides Pharma. Metronidazole.
As of Nov 21, 2026, ANDA 70039 (Metronidazole), held by Strides Pharma, was first approved by FDA on Jan 29, 1985, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 29, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metronidazole500MG · tablet;oral | Metronidazole | Discontinued |
| Oct 15, 2024 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jul 8, 2024 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jan 5, 2024 | Supplement 16Labeling · Standard review | Approved | None posted |
| Mar 31, 2022 | Supplement 15Labeling · Standard review | Approved | None posted |
| Aug 19, 2021 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jul 29, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Apr 16, 1992 | Supplement 11Labeling | Approved | None posted |
| Nov 1, 1988 | Supplement 8Bioequivalence | Approved | None posted |
| Jun 16, 1988 | Supplement 6Labeling | Approved | None posted |
| May 23, 1986 | Supplement 2Manufacturing | Approved | None posted |
| May 23, 1986 | Supplement 3Manufacturing | Approved | None posted |
| Jan 29, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters